11 Lymph node ratio is an independent risk classifier in node positive breast cancer patients: results of the phase III BIG 02-98 trial
2010 ◽
Vol 8
(3)
◽
pp. 61
◽
Keyword(s):
2018 ◽
Vol 49
(1)
◽
pp. 22-28
◽
2010 ◽
Vol 210
(5)
◽
pp. 797-805.e1
◽
Keyword(s):
2016 ◽
2010 ◽
Vol 6
(2)
◽
pp. 130-137
◽
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 24
(2)
◽
pp. 354-364
◽
Keyword(s):
2011 ◽
Vol 130
(2)
◽
pp. 507-515
◽
Keyword(s):